NCT06723080

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2024-12-30Est. Completion: 2027-08-30

Enrollment target: 480 participants

Locations

Chinese Academy of Medical Sciences Hospital for Skin Diseases, Nanjing, Jiangsu, China

Contact

Psoriasis

Psoriasis is an inflammatory skin disease with huge negative impact on the quality of life of the patients, and has an o…

Hong Kong, Hong KongCompleted Mar 27, 2026

Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is an inflammatory skin disease that causes painful lesions in the axilla (underarm), ingu…

Birmingham, United StatesEst. completion Mar 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.